About Us

Advalife Science Group

HOME

>

About Us

>

Advalife Science Group

From research and drug discovery through manufacturing and CMC to clinical trials, clinical development, patient care and real-world data, each organisation contributes its own specialist function.

Each organisation holds its own expertise and its own role, and together they form a development structure that connects research, drug discovery and clinical practice.


Structure

How research, development and clinical practice connect

DISCOVERY & RESEARCH

General Incorporated Association Advalife Science

Responsible for the discovery and development of new drug candidates, scientific validation, intellectual property, and joint research and academic collaboration.

MANUFACTURING & CMC

NOVARK BIO Co.,Ltd

Responsible for pharmaceutical functions including manufacturing and CMC, process development, formulation and injectable development, and quality control.

CLINICAL DEVELOPMENT & CRO

Medbis Co., Ltd.

Responsible for clinical trials and clinical development support, and for the sale and supply of research materials.

CLINICAL NETWORK & RWD

Sinclair Clinical Network

Through three healthcare institutions — Ginza, Shinsaibashi and Blue Front Shibaura — this provides the clinical base for patient care, everyday clinical practice and the real-world data that follows from it.


Roles

Drug discovery research and intellectual property

General Incorporated Association Advalife Science

Manufacturing and CMC

NOVARK BIO Co.,Ltd

Clinical development support / supply of research materials

Medbis Co., Ltd.

Patient care, clinical practice and real-world data

Sinclair Clinical Network (three institutions)


Collaboration

How we collaborate

Each company and each healthcare institution maintains its own legal responsibilities and its own expertise, and shares the information and the decisions that each stage of development requires. Research results are carried through to intellectual property, joint research, non-clinical work, manufacturing and CMC, and clinical development, and each programme is advanced through collaboration with universities, research institutions and pharmaceutical companies in Japan and abroad.

Contact us

Enquiries about the organisation, research collaboration and business partnerships, and media requests are all received here.